Nonkululeko B. Mzindle
Johannesburg, GT, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
SARS-CoV-2 vaccines elicit differential Fc effector functions.
Journal: iScience
Published: January 15, 2025
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.
Journal: Journal of virology
Published: July 02, 2024
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
Journal: PLOS global public health
Published: December 04, 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
Journal: medRxiv : the preprint server for health sciences
Published: December 04, 2023
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages.
Journal: Scientific reports
Published: September 09, 2022
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial.
Journal: The Lancet. Infectious diseases
Published: July 25, 2022
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms.
Journal: Scientific reports
Published: March 21, 2022
Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies.
Journal: PLoS pathogens
Published: March 18, 2022
SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals.
Journal: Cell host & microbe
Published: February 11, 2022
AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2.
Journal: BMC medicine
Published: February 02, 2022
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern.
Journal: Cell reports. Medicine
Published: January 03, 2022
Last Updated: 09/26/2026